Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead Sciences, Inc. $GILD Position Decreased by Brown Advisory Inc.
04:24am, Sunday, 07'th Dec 2025
Brown Advisory Inc. reduced its holdings in Gilead Sciences, Inc. (NASDAQ: GILD) by 6.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC
SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), and its partner Arcellx, today announced new positive data from its pivotal iMMagine-1 Phase 2 study of anitocabtagene aut
SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), presented Phase 1 data today with encouraging efficacy and safety results for its two investigational bicistronic CAR T-ce
Gilead Sciences, Inc. $GILD Shares Bought by CW Advisors LLC
05:54am, Friday, 05'th Dec 2025
CW Advisors LLC lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 309.2% during the second quarter, according to the company in its most recent disclosure with the Securities and E
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
10:01am, Thursday, 04'th Dec 2025
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Groupe la Francaise Has $3.92 Million Stake in Gilead Sciences, Inc. $GILD
04:43am, Thursday, 04'th Dec 2025
Groupe la Francaise grew its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 1,467.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
Gilead Sciences, Inc. (GILD) Presents at Evercore 8th Annual Healthcare Conference Transcript
03:13pm, Wednesday, 03'rd Dec 2025
Gilead Sciences, Inc. (GILD) Presents at Evercore 8th Annual Healthcare Conference Transcript
Gilead Sciences, Inc. (GILD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
01:23am, Wednesday, 03'rd Dec 2025
Gilead Sciences, Inc. (GILD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Capital Counsel LLC NY Buys 1,058 Shares of Gilead Sciences, Inc. $GILD
04:16am, Monday, 01'st Dec 2025
Capital Counsel LLC NY increased its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 1.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 69,210 s
BLI Banque de Luxembourg Investments Reduces Holdings in Gilead Sciences, Inc. $GILD
03:30am, Monday, 01'st Dec 2025
BLI Banque de Luxembourg Investments lowered its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 7.8% in the undefined quarter, according to the company in its most recent filing with the SEC. The
Aspire Growth Partners LLC Takes $212,000 Position in Gilead Sciences, Inc. $GILD
03:26am, Saturday, 29'th Nov 2025
Aspire Growth Partners LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ: GILD) in the undefined quarter, according to the company in its most recent filing with the SEC. The fund
Why Gilead Sciences (GILD) is a Top Momentum Stock for the Long-Term
10:51am, Friday, 28'th Nov 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now?
09:36am, Friday, 28'th Nov 2025
GILD's HIV strength, new approvals, and rising estimates set it apart as it edges past a challenged rival in growth prospects.
Gilead Sciences: About To Break Out
06:17am, Tuesday, 25'th Nov 2025
Gilead Sciences remains a bullish pick, with raised guidance and strong Q3/25 results, driving optimism for continued growth. Gilead Sciences key growth drivers, include robust sales from Livdelzi and
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term
10:41am, Monday, 24'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
